Catalyst Wire Dossier Catalyst Wire Dossier

FXFM244

· Vyne Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FXFM244, covering 2013-08-15 to 2013-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients [Phase 2]

See pricing